Annual Meeting

Discover BMB 2024 symposia: What are they really all about?

ASBMB Today Staff
Sept. 21, 2023

Back in June, the organizers of Discover BMB 2024 announced the titles and organizers of the thematic symposia for the American Society for Biochemistry and Molecular Biology’s annual meeting, scheduled to take place March 23–26 at the Henry B. Gonzalez Convention Center, in San Antonio. 

But you want to know more than the names of these sessions. Click on the links below to read what each symposium’s organizers have to say about their sessions, including who will be speaking, who should attend, —  even their theme song.

Dive deeper into what #DiscoverBMB programming will be all about.

Biochemistry of the multitudes

Microbial signaling, communication and metabolism

Peter Chien, University of Massachusetts, Amherst; Jade Wang, University of Wisconsin, Madison

Enzymes: Still cool after all these years

Cool and novel enzymes

Shelley Copley, University of Colorado, Boulder; Hung-wen (Ben) Liu, The University of Texas at Austin

Processing and translating RNA in health and disease

RNA biology

Katrin Karbstein, University of Florida, Scripps Biomedical Research; Jeremy Wilusz, Baylor College of Medicine

Our coolest superpower: Seeing all the atoms

New frontiers in structural biology

Jose Rodriguez, University of California, Los Angeles; Hosea Nelson, California Institute of Technology

Building natural products

Advances in natural product biochemistry and biotechnology

Yi Tang, University of California, Los Angeles; Katherine Ryan, University of British Columbia 

Dancing with metals: Iron, copper and reactive sparks

Redox and metals in biology

Siavash Kurdistani, University of California, Los Angeles; Gina DeNicola, Moffitt Cancer Center 

MCSs stick the landing

Membrane contact sites

Chris Beh, Simon Fraser University; Jen Liou, University of Texas Southwestern Medical Center

Lipids hold it all together

Lipid metabolism

Maria Fedorova, Dresden University of Technology; Neale Ridgway, Dalhousie University

Out with the old, in with the nucleus

Signaling mechanisms in the nucleus

Glen Liszczak, University of Texas Southwestern Medical Center; Aaron Johnson, University of Colorado Anschutz Medical Campus 

The specialized metabolism and trafficking of cellular subcompartments

Mitochondria, peroxisomes and chloroplast metabolism

Pere Puigserver, Harvard Medical School; Greg Moorhead, University of Calgary

Biochemists face the climate challenge

Maximizing Access Committee

Kayunta Johnson–Winters, University of Texas–Arlington; Karla Neugebauer, Yale School of Medicine 

Stressed out? The cancer playbook may help

Maximizing Access Committee

Jonathan Kelber, Baylor University

Teaching and engaging Gen Z: Two sides of the same coin

Education and professional development

Saumya Ramanathan, Arizona State University

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
ASBMB Today Staff

This article was written by a member or members of the ASBMB Today staff.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Glow-based assay sheds light on disease-causing mutations
Journal News

Glow-based assay sheds light on disease-causing mutations

Sept. 2, 2025

University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.